Anonymous User
Login / Registration

a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2023; 77(4): 322–325. doi: 10.48095/ccgh2023322.

Why should we and should we not use ChatGPT in gastroenterology?

Marek Bužga  1, Jan Král2,3, Kateřina Waloszková2, Jana Selucká2, Evžen Machytka2, Julius Špičák2

+ Affiliation


Artificial intelligence (AI) is increasingly being incorporated into medicine, including gastroenterology, opening new possibilities for the diagnosis and treatment of digestive tract diseases. ChatGPT, an AI model based on the GPT-4 architecture, has the potential to accelerate diagnosis and treatment, personalize care, educate, and train healthcare professionals, support decision-making, and improve communication with patients. However, with the use of AI come challenges such as the limited ability of AI to replace human judgment, data errors, issues related to security and personal data protection, and implementation costs. The future of ChatGPT in gastroenterology depends on its ability to process and analyze large amounts of data to identify patterns and create individual treatment plans. Thanks to advancements in AI and machine learning, ChatGPT is becoming more accurate and efficient, enabling faster diagnosis and treatment of gastroenterological diseases. In the field of education, ChatGPT will serve as an invaluable source of information on the latest research articles and procedures. Despite the benefits of AI in gastroenterology, it is essential to address issues of ethics, data protection, and collaboration between AI and healthcare professionals. Ensuring proper protocols and procedures will enable the safe and ethical use of AI in medicine. Although AI offers significant potential for improving the quality of care, it is necessary to address challenges associated with data protection, security, and ethics.


artificial intelligence, AI, ChatGPT, gastroenterology

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users


1. Egger J, Gsaxner C, Pepe A et al. Medical deep learning-A systematic meta-review. Comput Methods Programs Biomed 2022; 221: 106874. doi: 10.1016/j.cmpb.2022.106874.
2. Lahat A, Shachar E, Avidan B et al. Evaluating the use of large language model in identifying top research questions in gastroenterology. Scientific reports 2023; 13(1): 4164. doi: 10.1038/s41598-023-31412-2.
3. Chuah KH, Chan WK. Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future. Clin Mol Hepatol 2023; 29(2): 401–403. doi: 10.3350/cmh. 2023.0062.
4. Ashton JJ, Brooks-Warburton J, Allen PB et al. The importance of high-quality ‚big data‘ in the application of artificial intelligence in inflammatory bowel disease. Frontline Gastroenterol 2023; 14(3): 258–262. doi: 10.1136/flgastro-2022-102342.
5. Le Berre C, Sandborn WJ, Aridhi S et al. Application of Artificial Intelligence to Gastroenterology and Hepatology. Gastroenterology 2020; 158(1): 76–94 e2. doi: 10.1053/j.gastro.2019.08.058.
6. Wang F, Preininger A. AI in Health: State of the Art, Challenges, and Future Directions. Yearb Med Inform 2019; 28(1): 16–26. doi: 10.1055/s-0039-1677908.
7. Zhuang H, Zhang J, Liao F. A systematic review on application of deep learning in digestive system image processing. Vis Comput 2021: 1–16. doi: 10.1007/s00371-021-02322-z.
8. Seong D, Choi YH, Shin SY et al. Deep learning approach to detection of colonoscopic information from unstructured reports. BMC Med Inform Decis Mak 2023; 23(1): 28. doi: 10.1186/s12911-023-02121-7.
9. Barrett JS, Oskoui SE, Russell S et al. Digital Research Environment (DRE) -enabled Artificial Intelligence (AI) to facilitate early stage drug development. Front Pharmacol 2023; 14: 1115356. doi: 10.3389/fphar.2023.1115356.
10. Palmer A, Schwan D. More Process, Less Principles: The Ethics of Deploying AI and Robotics in Medicine. Camb Q Healthc Ethics 2023: 1–14. doi: 10.1017/S0963180123000087.

Credited self-teaching test